Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01414712 · ClinicalTrials.gov registry record
Circulating Tumor Cells in Prostate Cancer Patients
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Terminated
- Registry status
- 2
- Enrollment target
NCT01414712: Clinical Trial study, sponsored by University of Texas Southwestern Medical Center.
NCT01414712 is a clinical trial that was terminated before completion, run by University of Texas Southwestern Medical Center. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01414712 was terminated before completion, sponsored by University of Texas Southwestern Medical Center.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if a non-invasive cancer treatment, high-dose stereotactic body radiotherapy (SBRT), is associated with changes in circulating tumor cells counts in patients with low- and intermediate-risk prostate cancer.
Primary Outcome
The investigator will review the coutns of circulating tumor cells (CTC). If there are significant changes in CTC levels with radiation, future studies will determine the prognostic significance of this information.
Interventions
- OTHER Blood Drawing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2011-07 |
| Est. Completion | 2011-12 |
Why NCT01414712 stopped before completion
NCT01414712 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Blood Drawing is the first listed.
NCT01414712 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01414712 about?
NCT01414712 is a clinical study titled "Circulating Tumor Cells in Prostate Cancer Patients". The purpose of this study is to determine if a non-invasive cancer treatment, high-dose stereotactic body radiotherapy (SBRT), is associated with changes in circulating tumor cells counts in patients with low- and intermediate-risk prostate cancer.
What is the current status of trial NCT01414712?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2011-07. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01414712?
The interventions under investigation include: Blood Drawing (OTHER).
Who is sponsoring clinical trial NCT01414712?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia